Literature DB >> 10489919

Fatal fulminant hepatic failure due to cyproterone acetate.

G Friedman1, E Lamoureux, A H Sherker.   

Abstract

Cyproterone acetate is a normally well-tolerated drug that is used widely for the treatment of prostatic carcinoma. Liver toxicity due to its use is not well known. We describe two cases of fatal fulminant hepatitis related to the use of cyproterone acetate.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10489919     DOI： 10.1023/a:1026639432428

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  7 in total

1.  Fulminant hepatitis due to cyproterone acetate.

Authors:  H Lévesque; C Trivalle; N D Manchon; J P Vinel; N Moore; J Hémet; H Courtois; E Bercoff; J Bourreille
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

2.  Hepatocellular damage by cyproterone acetate.

Authors:  W H Meijers; P H Willemse; D T Sleijfer; N H Mulder; J Grond
Journal:  Eur J Cancer Clin Oncol       Date:  1986-09

3.  Cyproterone acetate: hepatotoxicity and prostatic cancer treatment.

Authors:  F Roila; L Crinò; G Carloni; G Natalini
Journal:  Ann Oncol       Date:  1993-09       Impact factor: 32.976

4.  Fatal fulminant hepatitis from cyproterone acetate.

Authors:  D Hirsch; S Kovatz; J Bernheim; L Shenkman
Journal:  Isr J Med Sci       Date:  1994-03

5.  [Fatal hepatitis caused by cyproterone acetate].

Authors:  L Bressollette; A Dubois; D Carlhant; C Morand; D Mottier; C Riche
Journal:  Therapie       Date:  1994 Mar-Apr       Impact factor: 2.070

6.  Severe hepatitis caused by cyproterone acetate.

Authors:  J C Blake; A M Sawyerr; J S Dooley; P J Scheuer; N McIntyre
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

7.  Severe hepatocellular dysfunction following cyproterone acetate therapy.

Authors:  B T Parys; S Hamid; R G Thomson
Journal:  Br J Urol       Date:  1991-03
  7 in total
  4 in total

1.  Toxic hepatitis after sequential administration of flutamide and cyproterone acetate.

Authors:  Spilios Manolakopoulos; Sotirios Bethanis; Anastasios Armonis; Michalis Economou; Alec Avgerinos; Dimitrios Tzourmakliotis
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

2.  Hepatic failure induced by cyproterone acetate: A case report and literature review.

Authors:  Jae Heon Kim; Byung Wook Yoo; Won Jae Yang
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 3.  Hepatotoxicity induced by cyproterone acetate: a report of three cases.

Authors:  Ioanna Savidou; Melanie Deutsch; Aspasia S Soultati; Dimitrios Koudouras; Georgia Kafiri; Spyridon P Dourakis
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

Review 4.  Hormonal Therapy for Prostate Cancer.

Authors:  Kunal Desai; Jeffrey M McManus; Nima Sharifi
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.